Skip to main content
. 2017 May 5;313(1):H114–H124. doi: 10.1152/ajpheart.00014.2017

Table 2.

RMSE from the exponential model curve fit of on-transient pulmonary V̇o2 kinetics in both heart failure patients and age-matched healthy control subjects

Healthy Control Subjects
Heart Failure Patients
RMSE PLB FNT PLB FNT
Phase I duration (25 s)
    Single exponential 0.040 ± 0.011 0.045 ± 0.022 0.052 ± 0.014 0.050 ± 0.014
    Double exponential 0.045 ± 0.009 0.048 ± 0.016 0.051 ± 0.015 0.048 ± 0.015
Single-exponential phase II pulmonary V̇o2 on-kinetics curve fit
Phase I duration, s
    Model 1 (15 s) 0.045 ± 0.010 0.046 ± 0.021 0.054 ± 0.015 0.052 ± 0.013
    Model 2 (25 s) 0.040 ± 0.011 0.045 ± 0.022 0.052 ± 0.014 0.051 ± 0.014
    Model 3 (35 s) 0.038 ± 0.012 0.042 ± 0.019 0.050 ± 0.013 0.048 ± 0.013

Data are expressed as means ± SD. Phase I durations of 15-s, 25-s, or 35-s length correspond to removal of data from time = 0 to 10, 20, or 30 s, respectively. RMSE, root mean square error; PLB, placebo experimental arm; FNT, fentanyl experimental arm.